Clinical Trials Logo

Irritable Colon clinical trials

View clinical trials related to Irritable Colon.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01855711 Completed - Irritable Colon Clinical Trials

Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)

Start date: September 18, 2003
Phase: Phase 2
Study type: Interventional

This study is an exploratory study aiming (i) to obtain clinical experience of GR68755 in Japanese subjects with severe d-IBS to explore the feasibility of the next phase study and (ii) to obtain reference data for endpoints and dosage and administration of a next phase study.

NCT ID: NCT00385099 Completed - Irritable Colon Clinical Trials

Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome

Start date: December 8, 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to see if GW876008 in Irritable Bowel Syndrome patients will reverse stress-induced hypersensitivity, by looking at thresholds for perception and pain.

NCT ID: NCT00376896 Completed - Clinical trials for Irritable Bowel Syndrome (IBS)

Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers

Start date: November 2006
Phase: Phase 1
Study type: Interventional

This is a three-period crossover study to compare GW876008 and placebo to see if GW876008 will normalise blood flow responses after different emotional stimuli.

NCT ID: NCT00370032 Completed - Irritable Colon Clinical Trials

Study to Assess the Effect Of Alosetron On Mucosal Blood Flow

Start date: December 2006
Phase: Phase 4
Study type: Interventional

This study will look at colonic mucosal blood flow in subjects who have taken alosetron vs placebo and healthy volunteers vs diarrhea-predominant Irritable Bowel Syndrome (d-IBS) patients.

NCT ID: NCT00101985 Completed - Irritable Colon Clinical Trials

Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)

Start date: October 2004
Phase: Phase 2
Study type: Interventional

This study will evaluate the effectiveness and safety of the investigational drug talnetant in treating subjects with irritable bowel syndrome (IBS).

NCT ID: NCT00067561 Completed - Clinical trials for Irritable Bowel Syndrome (IBS)

Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy

Start date: June 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and effectiveness of different doses of an investigational medication in women with severe diarrhea-predominant Irritable Bowel Syndrome (IBS) who have failed conventional therapy.

NCT ID: NCT00067457 Completed - Clinical trials for Irritable Bowel Syndrome (IBS)

Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy

Start date: June 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and effectiveness of as needed versus fixed dosing of an investigational medication for women with severe diarrhea-predominant Irritable Bowel Syndrome (IBS) who have failed conventional therapy.